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ABSTRACT
The gata2 gene encodes a transcription factor
implicated in regulating early patterning of ectoderm
and mesoderm, and later in numerous cell-specific
gene expression programs. Activation of the gata2
gene during embryogenesis is dependent on the
bone morphogenetic protein (BMP) signaling path-
way, but the mechanism for how signaling controls
gene activity has not been defined. We developed
an assay in Xenopus embryos to analyze regulatory
sequences of the zebrafish gata2 promoter that are
necessary to mediate the response to BMP signaling
during embryogenesis. We show that activation is
Smad dependent, since it is blocked by expression
of the inhibitory Smad6. Deletion analysis identified
an octamer binding site that is necessary for BMP-
mediated induction, and that interacts with the
POU homeodomain protein Oct-1. However, this
element is not sufficient to transfer a BMP response
to a heterologous promoter, requiring an additional
more proximal cooperating element. Based on
recent studies with other BMP-dependent promoters
(Drosophila vestigial and Xenopus Xvent-2), our
studies of the gata2 gene suggest that POU-domain
proteins comprise a common component of the
BMP signaling pathway, cooperating with Smad
proteins and other transcriptional activators.
INTRODUCTION
Bone morphogenetic proteins (BMPs) are members of the
TGF-b superfamily of extracellular ligands, which signal by
binding to heterodimeric serine/threonine kinase receptor
complexes. Much progress has been made identifying the
molecular components that regulate transduction of a BMP
signal from the plasma membrane to the nucleus (1,2). Ligand
binding activates the receptor complex, which relays the
signal by recruiting downstream mediators. A commonly used
subset of mediators are known collectively as Smads, which
are categorized into three functional groups: (i) receptor
regulated Smads (R-Smads) that are directly phosphorylated
by the activated receptor; (ii) Smad4, which cooperates
with R-Smads to form an active signaling complex; and
(iii)inhibitorySmads(I-Smads),which serveasnegativeregu-
lators of the pathway (3). Although there may be exceptions
(4,5), generally R-Smads 1, 5 and 8 are phosphorylated by the
BMP pathway, whereas R-Smads 2 and 3 function instead to
transduce a TGF-b, nodal or activin signal. The R-Smad/
Smad4 complex interacts with speciﬁc nuclear transcription
factors to activate gene transcription. There are also Smad-
independent mechanisms to mediate BMP signaling, e.g. by
p38 MAPK (6).
Deﬁning the mechanisms by which BMP-induced Smads
activate speciﬁc target genes is an important goal (7) given the
wide range of developmental and physiological responses that
are under the control of the pathway. BMP signaling patterns
early germ layers to establish a dorsal/ventral mesoderm
axis, the anterior/posterior endoderm character and the dis-
tinction of neural/epidermal ectoderm (8–12). BMP signaling
also regulates lineage and morphogenetic programs relevant to
bone, cartilage, kidney, heart and reproductive organ devel-
opment. Thus, a wide range of highly speciﬁc gene expression
programs is coordinated by the action of this common signal-
ing pathway, presumably by the presence or absence of inter-
secting signaling pathways and speciﬁc nuclear co-factors.
An R-Smad/Smad4 complex binds DNA weakly on its own,
relying on interaction with other nuclear partners to achieve
stable and functional binding (13). A paradigm of Smad–
cofactor interaction was established for TGF-b/activin signal-
ing by the identiﬁcation of winged helix proteins, such as
FAST-1 as DNA-binding partners that interact with Smad2/
3 at target promoters (14,15). With respect to the BMP path-
way, an analogous example is the 30-zinc ﬁnger protein OAZ,
shown to interact with BMP-induced Smads to activate the
promoter for the homeobox gene Xvent2 (16). Most, but not
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binding elements (SBEs), including those in the promoters
for the genes encoding Vestigial (17), xVent2B (16,18),
Smad6 (19), Id1 (20,21), Dlx3 (22) and Hex (23). A BMP-
4 syn-expression motif was identiﬁed (TGGCGCC) as a
conserved BRE (7), and SBEs have in some cases (17,24)
been associated with GC-rich elements (GCCGnCGC) or
as other deﬁned short (GTCT or GCAT) motifs (18,25).
However, there is no single consensus sequence that can
readily predict a functional Smad1 binding site. Given that
Smads have weak afﬁnity for DNA, it is necessary to deﬁne
the DNA-binding cofactor(s) to understand how Smads are
targeted to any particular BRE.
One of the best characterized BMP-regulated pathways
relates to the induction of ventral/posterior cell fate during
Xenopus development. The homeobox transcription factor
Xvent2 was the ﬁrst target gene of BMP signaling to be inves-
tigated mechanistically, and several elements that contribute
to BMP responsiveness have been deﬁned, including an SBE/
OAZBRE,GCATmotifs,Vent2auto-regulatorybindingsites,
and most recently, binding sites for the POU-domain protein
Oct-25 (26). Another gene important to the ventral pathway
is gata2, encoding a zinc ﬁnger transcription factor that is
expressed throughout ventral ectoderm and ventral and lateral
mesoderm (27–29). The gata2 gene is induced by BMP-4
(30,31) and forced expression of an engrailed-Gata2 fusion
protein is sufﬁcient to dorsalize Xenopus embryos (32), pro-
viding strong evidence that Gata factor activity is essential for
ventral cell fate. Gata2 and xVent2 cooperate to activate the
xVent1 gene, placing these two transcription factors within
a common ventral network (32,33). Here, we investigate the
mechanism by which the gata2 gene is activated by BMP
signaling. We establish a reporter assay to deﬁne sequences
ofthe gata2 promoter that mediate inductionby BMP-4 during
embryonic development. We ﬁnd that an octamer binding
site, interacting with Oct-1, is necessary for induction, but
only functions in the context of a separate more proximal
DNA sequence. The results provide an independent example
of a POU-homeodomain protein mediating induction by
BMP signaling, and implicate a common network controlling
regulatory genes of the ventral pathway.
MATERIALS AND METHODS
Identification of the zebrafish gata2 transcriptional
start site
RNA was isolated from zebraﬁsh embryos (75% epiboly) with
Tri-reagent (MRC, Inc.). Superscript Reverse Transcriptase
(BRL) was used to generate cDNA, followed by treatment
with RNAse. Adapters were ligated to the cDNA ends using
the Invitrogen 50 RACE kit as per the manufacturer’s instruc-
tions. A 30 gene-speciﬁc reverse primer, corresponding to
position +92 (relative to the translation start site) of the
gata2 transcript, was used to amplify cDNA by PCR. The
primer sequence was 50-GTAAGCCCGTGATGATGTGAC-
TCT (TE872). A single PCR product was identiﬁed in this
analysis and subcloned in pCR-2.1 TOPO (Invitrogen).
Sequence analysis conﬁrmed that the clone included the
previously characterized gata2 cDNA, with additional 50-
untranslated region. The start site and exon/intron boundaries
were determined by comparing this new cDNA sequence with
the genomic sequence.
Reporter plasmids and deletion constructs
A genomic region including  7.1 kb of sequence upstream of
the initiation methionine (6.5 kb upstream of transcriptional
start site) was provided by Shuo Lin (UCLA), and transferred
to the Kpn1 site of the pGL3basic luciferase reporter plasmid
(Promega). The deletion to  1070 was facilitated by a unique
MluI restriction site at that position. The other 50 deletion
constructs were generated by PCR, incorporating in the
upstream primer a KpnI site and using a reverse primer cor-
responding to position +58 of the gata2 promoter. PCR prod-
ucts were cloned into the pCR-2.1 TOPO vector (Invitrogen).
Subsequent cloning steps took advantage of an internal BssH2
site located at position  97. Therefore, each PCR-derived
clone was digested with KpnI/BssH2 and the fragment used
to substitute the full-length gata2 promoter sequence in the
context of the pGL3basic luciferase reporter. PCR primers
used to generate the progressive deletions were (KpnI sites
underlined):  890 Kpn I forward, 50-AAAGGTACCGCCT-
GCTGCTTGTTTTGCC (TE851);  819 KpnI forward,
50-AAAGGTACCGGCTTTATTTGGACCTGC (TE876);
 751 KpnI forward, 50-AAA GGTACCAAGTGACGTTT-
GATCGCT (TE878);  728 KpnI forward, 50-AAAGG-
TACCCGGCATACAAAGACAGTG (TE852); +58 reverse,
50-CCCGATTGTTAAAGTCTCCC (TE837).
To transfer a ‘minimal’ BRE region upstream of the SV40
promoter, a ClaI site at position  443 was used with promoter
constructs truncated at  819 or  751. Plasmids were digested
with KpnI/ClaI, transferred ﬁrst into pBluescript KS digested
with KpnI/ClaI, re-excised with KpnI and SmaI, and ﬁnally
transferred into similarly digested SV40 pGL3promoter
luciferase plasmid (Promega). This resulted in reporter plas-
mids that transfer from  819 to  443 (377 bp) or  751 to
 443 (308 bp) of the gata2 promoter, respectively. Additional
minimal promoter constructs (which transfer 233, 184 or
134 bp) were generated by PCR, ﬁrst cloning products into
pCR-2.1 TOPO, followed by re-excision with KpnI and
SacI, and transfer into the KpnI/SacI sites of the SV40
pGL3promoter luciferase plasmid (Promega). This resulted
in the transfer of regions  819 to  586 (233 bp),  819 to
 635 (184 bp), or  819 to  685 (134 bp), respectively. The
PCR primers used for this purpose were (restriction sites
underlined):  819 KpnI forward, 50-AAAGGTACCGGCTT-
TATTTGGACCTGC (TE 876);  685 SacI reverse, 50-AAA-
GAGCTCGTCACCACATTCTTCTTG (TE 1127);  635
SacI reverse 50-AAAGAGCTC CTCTAAATTGGGGGCTA-
TTG(TE1161); 586SacIreverse,50-AAAGAGCTCCTCAA
CTCCTAGCACCTC (TE1128).
For site-directed mutagenesis, the GeneEditor in vitro
mutagenesis system (Invitrogen) was used with the follow-
ing oligonucleotides (mutations underlined): mutation #1,
50-TCGATAGGTACCACTTTTATTTGGACC (TE1009);
mutation #2, 50-ACCGGCTTTATTGCTACCTGCCCATGC
(TE1012); mutation #3, 50-GGCTTTATTTGGGAGTGC-
CCATGCGAC (TE1013); mutation #4, 50-TGGACCTG-
CCCAAAGGACCTGTCGGCAC (TE1016); mutation #5,
50-CACCTCCAAGAGACTAGTTCGCTATTAATATGTAA-
AGTG (TE1134); mutation #6, 50-AGAGACGGGCTCGC-
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GGGCTCGCTATTAAGCTTTAAAGTGACGTTTGATCG
(TE1147).
In vitro transcription
RNA used for micro-injection was obtained by in vitro
transcription using linearized pCS2 vectors. The vectors
were pCS2-lacZ, pCS2-xSmad1 (from J. Thomsen), pCS2-
zSmad5 (from M. Mullins), pCS2-xSmad6 (from J. Christian),
pCS2-xSmad8 (34) and pCS2-BMP4 (from C. Wright) were
used as templates for in vitro transcription. One microgram of
linearized template was used to generate capped mRNAs with
the mMessage mMachine kit (Ambion), followed by precip-
itation with LiCl. RNA was quantiﬁed by optical density, and
integrity was conﬁrmed by gel electrophoresis.
Microinjection and luciferase assays
Eggs were obtained from female Xenopus by standard
gonadotropin induction protocols. Eggs were fertilized
in vitro and dejellied in a solution of 2% cysteine (pH 8.0).
Microinjection was performed with embryos in 0.1· MBS and
5% Ficoll. Each injection mix contained 62.5 pg of RNA
encoding either BMP-4 or an irrelevant control RNA (such
as lacZ), 25 pg of luciferase reporter DNA and 0.10 pg of RNA
encoding Renilla luciferase (to normalize reporter activity). In
some experiments, 250 pg of RNA encoding either xSmad1,
zSmad5 orxSmad8 was includedin place of BMP-4 RNA. In a
standard assay, mixes were injected into the two dorsal blas-
tomeresofafour-cellstageembryo. Togenerate lysatesforgel
mobility shift experiments, RNA was injected at the two-cell
stage.
Embryos were staged according to Nieuwkoop and Faber
(35). Following microinjection, embryos were cultured in
0.1· MBS until stage 13, at which point embryos were col-
lected and lysed in 1· Passive Lysis Buffer (Promega).
Luciferase assays were performed according to the manufac-
turer’s instructions. For each assay, four embryos were lysed
in 100 ml of buffer, and typically 3–5 sets were used to gen-
erate independent data points for each independent experi-
ment, using 5 ml of lysate per 50 ml of luciferase substrate,
measured in a Turner TD-20e luminometer. The ﬁreﬂy
luciferase values were divided by corresponding values for
the control Renilla luciferase. Normalized data from embryos
injected with BMP-4 was divided by normalized numbers
obtained from embryos injected with control RNA to deter-
mine ‘BMP-4 fold induction’. All luciferase data represent
averages of at least three independent microinjection experi-
ments. Error bars in the ﬁgures indicate standard error of
the mean.
Preparation of Xenopus nuclear and total cell extracts
Total cell extracts were prepared by freezing embryos in liquid
N2, followed by homogenization in total cell extract buffer
(50 mM Tris–HCl, pH 8.0, 400 mM KCl, 1 mM DTT, 25%
glycerol, 50 mM NaF and protease inhibitors). Extracts
were cleared by centrifugation three times for 10 min at
8160g 10–20 mg per reaction was used in gel mobility shift
reactions. To generate nuclear extracts, a nuclear pellet was
obtained from stage 13 embryos as described (36). The pellet
was resuspended in Buffer C (20 mM HEPES–KOH, 25%
glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT and protease inhibitors) on ice and centrifuged
at 10000 g in a microfuge for 1 min at 4˚C to clear contami-
nating pigment granules: 1–5 mg was used for each gel mobil-
ity shift assay. To obtain lysates from embryos expressing
BMP-4, embryos were injected at the two-cell stage with
500 pg of RNA and harvested at stage 13. Total protein con-
centration for all experiments was obtained using a modiﬁed
Bradford assay (BioRad).
Gel mobility shift assays
Oligomers were gel-puriﬁed prior to use as probes or cold
competitors. For probes, the top strand was end-labeled
with [g-
32P]ATP using T4 polynucleotide kinase, followed
by puriﬁcation thorough a G-25 Sepharose column. The radio-
labeled top-strand was annealed with the complementary bot-
tom strand by heating to 95 C for 5 min in 0.1 M NaCl, and
then gradually cooling the reaction to room temperature. Cold
competitors were prepared identically, without labeling. For
super-shift experiments, reactions included 0.5 mg of anti-
Oct-1 antibody (sc–8024, Santa Cruz) or 0.5 mg of control
isotype-matched antibody (various, but the one shown is
anti-Chicken Gata2, sc-267). Gels were run and analyzed as
described (37).
The sequences of the top strand of the oligomers are
as follows:  763 to  737, 50-AGCTTATTAATATGTAAA-
GTGACGTTTGATA (TE1175);  763 to  737 (mutated), 50-
AGCTTATTAAGCATTAAAGTGACGTTTGATA (TE1191);
Octamer consensus, 50-CGAATATGCAAATAAGGC
(TE1189); CCAAT, 50-ACTGGCTGGCGGAGGCTTGTGA-
TTGGCTGGCCCGG (TE1207).
RESULTS
The gata2 promoter is induced by BMP signaling
The gata2 gene isactivated atthe transcriptional levelby BMP
signaling, but the mechanism for induction is not known.
Previous transgenic reporter experiments demonstrated that
7.3 kb of sequences upstream of the zebraﬁsh gata2 initiation
ATG are sufﬁcient to direct appropriate expression of a
reporter to the early ventral domain (38). We sought to deﬁne
the speciﬁc DNA regulatory elements that mediate transduc-
tion of the BMP signal to the gata2 gene. The gata2 gene
structure has been studied in a variety of organisms, including
human(39,40),mouse(41),chicken(42) and Xenopus (39,43).
Both the mouse and the chicken genes contain two alternative
ﬁrst exons (proximal and distal), and the different transcrip-
tional start sites are used depending on the cell type (41,42).
Alternative ﬁrst exons are not described for either the Xenopus
or human genes, but it remains possible that multiple promot-
ers are a common feature of the gata2 locus, and this could
complicate any mapping experiments. Therefore, before
attempting to map BMP responsive sequences, we ﬁrst iden-
tiﬁed the transcriptional start site for the zgata2 gene in order
to deﬁne the proximal promoter.
Sequence comparison of the zebraﬁsh gata2 putative pro-
moter region with DNA sequences from exon 1 of the gata2
gene from a variety of species failed to identify regions of
homology (data not shown). Therefore, to identify the
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of cDNA ends (RACE) was performed on RNA isolated from
embryos at 75% epiboly, the ﬁrst stage at which gata2 tran-
scripts are readily detected (44). A single PCR product was
obtained from this analysis, and subsequent sequencing and
comparison with the genomic sequence determined that the
transcription start site is located 595 bp upstream of the ini-
tiation methionine (Figure 1A). The analysis identiﬁes a short
non-coding ﬁrst exon and places the ATG initiation codon
within the second exon (Figure 1A and B). The cDNA isolated
by RACE includes sequences just upstream of an indepen-
dently isolated gata2 cDNA clone (45). No alternative
50 sequences that would suggest an alternative exon were
identiﬁed in the expressed sequence tag database. The exon
1 sequence does not show homology with gata2 genomic
sequences from other species. The result does not rule out
that additional promoters might be used in speciﬁc cell
types or later stages of development, but indicates that a proxi-
mal promoter functions during early embryogenesis, initiating
transcription at  595 bp upstream of the initiation ATG.
Therefore, we considered the  6.5 kb of sequences
upstream of this region as putative regulatory sequences
and developed an assaytodetermineifthey areable tomediate
a BMP response. Although it should be possible to do this
experiment in the homologous zebraﬁsh system, Xenopus
embryos provide a unique advantage in that the dorsal/ventral
axis is discernable as early as the four-cell stage. Furthermore,
the primary components of the early embryonic BMP signal-
ing pathway are thought to be highly conserved. Therefore, the
genomic sequence including the ATG was cloned upstream of
a ﬁreﬂy luciferase reporter gene (Figure 1C) and this plasmid
was injected into developing Xenopus embryos. This approach
allows activity of the reporter to be analyzed in vivo during the
early stages of embryogenesis when gata2 expression is
known to be dependent on BMP signaling. In the Xenopus
system, blastomeres committed to dorsal-anterior or ventral-
posterior fates can be distinguished already at the four-cell
stage, by virtue of pigment differences that arise following
cortical rotation. A reporter sensitive to the endogenous BMP
program is expected to be relatively more active when injected
at the four-cell stage into presumptive ventral-posterior blas-
tomeres compared to dorsal-anterior blastomeres. The reporter
was co-injected with control RNA expressing Renilla
luciferase. Preliminary experiments demonstrated that the
control luciferase is equally active regardless of the injected
blastomere (data not shown). The approach of using Renilla
luciferase RNA (rather than a Renilla luciferase expression
plasmid) avoids any potential concern that BMP-4 might also
inﬂuence a control promoter. Embryos were harvested at stage
12–13 (during early neurulation) and protein lysates were
tested for the relative amount of ﬁreﬂy luciferase, normalized
to Renilla luciferase.
We found that the gata2:luciferase reporter is more active
when injected into the two ventral-posterior blastomeres of a
four-cell embryo compared to activity when injected into the
two dorsal-anterior blastomeres (Figure 2A). The difference is
 2-fold, consistent with the gradient of BMP signaling across
the dorsal/ventral axis. Importantly, co-injection of RNA
encoding Xenopus Smad6 (xSmad6), which block BMP sig-
naling (46–48), reduces the activity of the reporter when
injected into ventral blastomeres to a level below what is
found when the reporter is injected into dorsal-anterior
blastomeres (Figure 2A). Thus, the reporter responds to the
embryonic BMP program in a manner consistent with the
endogenous pathway. To demonstrate directly that the reporter
is activated by the BMP pathway, the gata2 and control
reporter constructs were co-injected with RNA encoding
BMP-4 into the two dorsal blastomeres. In this assay, the
activity of the injected BMP-4 is conﬁrmed by the subsequent
ventralized phenotype of injected embryos (data not shown).
As shown in Figure 2B, BMP-4 expression results in an
average 5-fold induction of reporter activity compared to
activity of the reporter when coinjected with control RNA.
Co-injection of Smad6 is sufﬁcient to block this activation to
the basal level activity of the promoter. We conclude that
6.5 kb of upstream gata2 genomic sequence is sufﬁcient to
respond to BMP signaling, and that the developing Xenopus
embryo can be used as a model system to deﬁne the relevant
cis elements.
Deletion analysis defines an upstream region required
for activation by BMP4
To deﬁne the BREs, a series of progressive 50 deletion con-
structs were each injected into developing Xenopus embryos
with either control RNA or RNA encoding BMP-4. In each
Figure 1. Structure of the zebrafish gata2 gene. (A) The diagram illustrates the exon/intron structure at the 50 end of the zebrafish gata2 gene, determined by
comparingthe50-RACEproductwiththegenomicsequence.Exonsareshownasboxesand+1indicatesthetranscriptionstartsite.(B)Thepositionofthefirstintron
relativetothegenomicsequenceisshown,withintronicsequencesinlowercase,andconservedintronicsplicejunctionsequencesinbold.(C)Togenerateareporter
gene, the sequences from the initiation ATG at +595 (relative to the transcription start site) to  6520 were placed upstream of the coding sequences for the firefly
luciferase gene. This construct is analogous to a transgenic reporter shown to recapitulate the early gata2 expression pattern in zebrafish embryos (38).
4360 Nucleic Acids Research, 2005, Vol. 33, No. 13case, the activity of the reporter was measured in luciferase
assays following injection into the two presumptive dorsal
blastomeres of a four-cell embryo, and normalized to Renilla
luciferase activity from co-injected Renilla luciferase RNA.
As shown in Figure 3, deletion of sequences from  6520
to  819 has no effect on the levels of induction caused by
BMP-4. However, removing a 68 bp region located between
 819 and  751 (relative to the start of transcription) results
in a signiﬁcant loss of induction, indicating that this region
mediates a response to BMP-4 and might contain one or
more BREs.
BMP-dependent Smads can activate the zgata2
promoter via the 68 bp BRE
We showed that the BMP response on the gata2 promoter is
sensitive to Smad6 (the inhibitory Smad), so it is expected that
BMP-dependent R-Smads should be at least part of the mecha-
nism that mediates the induction between  819 and  751,
although this could be direct or indirect. We therefore tested
whether injection of RNA encoding BMP regulated Smads 1,
5 or 8 could function throughthe gata2 BRE to induce reporter
activity. The reporter either contained the BRE ( 819) or
lacked the BRE ( 751), as illustrated in the diagram of
Figure 3. As shown in Figure 4, injection of mRNA encoding
Xenopus Smad1 (xSmad1) or zebraﬁsh Smad5 (zSmad5) was
sufﬁcient to activate the promoter containing the 68 bp BRE
( 819). Injection of Xenopus Smad8 (xSmad8) failed to acti-
vate the same reporter, indicating that not all BMP regulated
Smads can mediate this effect and that there are functional
distinctions between Smads 1, 5 and 8 [shown also in other
studies (34,49)]. Importantly, Smad1 failed to activate a
reporter construct deleted of the 68 bp BRE ( 751), indicating
that this region is required for both BMP-4 signaling and
Smad1 activity to induce the gata2 promoter. The experiment
does not distinguish whether Smads function directly by bind-
ing this promoter, but only that their activity is mediated by
the 68 bp sequence.
An Oct-1 binding site is a necessary element within
the 68 bp zGATA2 BRE
We ﬁrst considered whether sequences similar to previously
deﬁned SBEs exist within the 68 bp gata2 BRE identiﬁed by
the deletion analysis. Alignment of the region to the syntenic
region of the Fugu rubripes gata2 gene showed that the
A
B
Figure 2. The gata2 promoter directs reporter gene activity that is induced by
BMP4 and dependent on Smad signaling. (A) The luciferase reporter was
injected at the four-cell stage into blastomeres that contribute preferentially
to ventral or dorsal regions of the embryo, as indicated. The reporter is more
active in the ventral-posterior derivatives, but this is abrogated by co-injection
ofRNAencodingtheinhibitorySmad6(theerrorbarforthissampleispresent,
but it is so small that it is not evident). The results indicate that the reporter
respondsaspredictedtotheendogenousSmad-dependentBMPsignalingpath-
way. (B) The gata2 promoter is induced  5-fold by co-injection of RNA
encoding BMP4. This activation is also blocked by co-expression of Smad6.
Figure3.DeletionanalysismapsaBREtoa68bpregionupstreamofthegata2promoter.Aprogressiveseriesof50 deletionswasusedtomeasuretherelativeactivity
ofthepromoterwheninjectedwithRNAencodingBMP4,comparedtothesamereporterwheninjectedwithnon-codingcontrolRNA,asdescribedinMaterialsand
Methods.Foreachconstruct,thesiteoftruncationisindicated,the+1indicatesthetranscriptionalstartsite,andtheboxrepresentsthefireflyluciferasereporter.The
folddifference(induced/uninduced)isplottedandshowsasignificantdropwhensequencesaredeletedbetween 819and 751.This68bpsequenceisdesignated
BRE1.
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obvious clustering, and with no sequences that match perfectly
a known SBE. However, we tested several potential candidate
sequences by site-speciﬁc mutagenesis (Figure 5A). The
sequence 50-TGGAGC is important for mediating BMP-4
activation of the xVent2 promoter by directing the assembly
of a Smad1/Smad4/OAZ transcriptional complex (16). The
zebraﬁshgata2BREcontainsarelated sequence:50-TGGACC
(Figure 5A, #2 and 3). Also, Drosophila Mad binds to the
GC-rich sequence 50-GCCGnCGC (17), and a related
sequence 50-GGGCTCGC is present in the zebraﬁsh gata2
promoter (Figure 5A, #5). Both these elements and several
other sequences with some similarity to previously identiﬁed
SBEs (e.g. GGCT, Figure 5A, #1), or A/T-rich sequences
(Figure 5A, #6) were altered using site-directed mutagenesis.
However, none of these mutations (#1–6) had any effect on the
ability of BMP-4 to induce the promoter (Figure 5B).
Gel mobility shift assays using the 68 bp BRE as a probe
failed to reveal any speciﬁc protein complexes using whole
cell or nuclear extracts from Xenopus embryos injected with
xSmad1 or mSmad4 (data not shown). Neither GST–Smad1
nor GST–Smad4 fusion proteins were able to bind the 68 bp
Figure 4. BRE1 mediates activation by BMP4 or Smads. The inducible reporter ( 819) or the reporter lacking BRE1 ( 751), as diagrammed in Figure 3, was
co-injected into Xenopus embryos with RNA encoding Smad1, BMP4, Smad5 or Smad8, as indicated. Smad1 activates the reporter equivalent to BMP4, and in
both cases this is dependent on the presence of the BRE1 sequences. Smad5 is only slightly less active, while Smad8 fails to induce reporter activity.
Figure 5. Mutation of an octamer element located at the 30 end of the BRE1 is sufficient to block BMP-induced activation of the promoter. (A) A series of specific
mutationswereintroducedintotheBRE1bysite-directedmutagenesisforpotentialSmad-bindingsites(mutations#1–5)orforanA/T-richsequence(mutation#6),
oraputativeoctamerbindingsite(mutation#7).(B)WhencomparedtotheBMP-induciblereportercontainingtheintactBRE1( 819),noneofthefirstsixmutations
had a significant effect on induction. In contrast, mutation of the putative octamer binding site (mutation #7) blocked BMP-mediated induction, similar to deletion
of the BRE1 ( 751).
4362 Nucleic Acids Research, 2005, Vol. 33, No. 13sequence (data not shown). Although these are negative
results, they indicate that Smad proteins might not function
directly by binding sequences in this region. Therefore, we
considered other potential binding sites, and identiﬁed a strong
match with the consensus binding site (50-ATGCAAAT) for
the POU homeodomain transcription factor Oct-1 (50–52).
The related sequence 50-ATGTAAAG is truncated precisely
at the junction of the 68 bp deletion. Interestingly, Oct-1
binding is maximal if the ﬂanking sequences are A/T rich
(51), which is the case in the gata2 sequence. Mutation of
this putative Oct-1 binding site in the gata2 promoter nearly
eliminated induction of the promoter by BMP-4, equivalent to
truncationofthepromoterat 751(Figure5B,mutation#7).It
is important to point out that the mutation does not alter the
basal activity of the promoter, but only the activation by BMP.
Thus, the Oct-1 site mediates BMP responsiveness in this
system.
In gel mobility-shift assays, nuclear extracts derived from
stage 13 Xenopus embryos generate a single predominant
complex with a probe that is centered on the putative Oct-1
binding site (arrow in Figure 6A). This complex was not
detected using probes from the original 68 bp BRE, since
the octamer site is truncated on those sequences. This binding
activity is competed in the presence of excess unlabeled probe
corresponding to the wild-type sequence, but not with an
unlabeled oligomer probe corresponding to the mutated
sequence that fails to support a BMP response. Furthermore,
this complex is fully competed by an oligomer probe contain-
ing an Oct-1 consensus binding site (52). Finally, the complex
that forms with the wild-type probe derived from the gata2
BRE is super-shifted speciﬁcally by addition of a monoclonal
antibody raised against the C-terminus of the Xenopus Oct-1
protein (Figure 6B). Incubation with control isotype-matched
antibodies does not alter migration of the complex. Thus, Oct-
1 binds to the gata2 BRE (designated BRE1), and a mutation
that abolishes Oct-1 binding abrogates the ability of BMP-4 to
induce the gata2 promoter.
We tested if BMP signaling modiﬁes the interaction of
Oct-1 with the BRE1 site. For this purpose, fertilized eggs
were injected with BMP-4 RNA or control RNA. Nuclear
extracts were subsequently prepared from the embryos at stage
13 and compared for binding activities. Although extracts
from BMP-4 injected embryos appeared to have a modest
relative decrease in Oct-1 binding activity, this difference is
essentially the same difference found for a distinct complex
formed with a control oligomer containing a CCAAT binding
site (data not shown). Therefore, the amount and activity of
normalized Oct-1 complex formation is not obviously altered
by BMP-4 signaling.
The Oct-1 site is not sufficient for mediating the
BMP response, but cooperates with a downstream
element
Since BMP signaling does not appear to directly alter the
Oct-1 interaction with the BRE1, we next considered whether
Oct-1 cooperates with one or more additional complexes,
which themselves might be direct targets of BMP signaling.
Note also that the deletion of the BRE1 or mutation of the
Oct-1 site does not eliminate entirely the BMP response, typi-
cally reducing the effect from 5- to 2-fold, indicating that
additional proximal sequences might contribute to activity.
We ﬁrst tested whether the BRE1 was sufﬁcient to function
autonomously upstream of a heterologous promoter. Because
the Oct-1 binding site spanned the 30 junction of the 68 bp
region, a larger region of the gata2 promoter including the
Oct-1 site and ﬂanking sequences (134 bp, from  819 to
 685) was tested for the ability to mediate BMP responsive-
ness when placed as a single copy or in triplicate upstream of
the SV40 promoter. These sequences were unable to mediate a
BMP response with the SV40 promoter, indicating that the
Oct-1 dependent BRE1 is necessary but not sufﬁcient for
mediating induction (Figure 7A).
When a larger region including sequences downstream
of the BRE was tested (377 bp, from  819 to  443),
BMP-4 induction was conferred to the SV40 promoter. This
result is consistent with the presence of one or more cooper-
ating cis-elements located within the more proximal
sequences. Therefore, progressive 30 deletions were tested
to deﬁne the 30 boundary of this activity. As shown in
Figure 7A, sequences between positions  666 and  646
(BRE2) are required for conferring a BMP-4 response onto
the SV40 promoter. To conﬁrm that this sequence cooperates
with the original BRE1 deﬁned by the 50 deletion series (the
Oct-1 site), the upstream sequences were removed from the
context of the BRE2. Deletion of 68 bp from the larger 377 bp
Figure6.TheoctamersiteofBRE1bindsOct-1inXenopusnuclearlysates.(A)
Gel mobility shift assays were performed using a labeled probe containing the
BRE1sequencesincludingtheputativeoctamerbindingsite.Lane0represents
probe alone and the position of the free probe is indicated (P). In lanes marked
with a ‘+’, a specific complex forms using nuclear extracts derived from stage
13 embryos, as indicated by the arrow in the second lane. The complex is
competed specifically by the addition in the reaction of excess (10·,2 5 · or
100·) unlabeled probe DNA (self) or DNA containing the octamer consensus
(octamer), but not by DNA containing the same mutation of the octamer that
blocks the induction by BMP4 (mutant). (B) Similar gel mobility-shift assays
were performed. In this case, the lanes include probe alone (0), nuclear extract
(1), nuclear extract and antibody to Xenopus Oct-1 (2) or a control isotype-
matched antibody (3). The free probe is indicated (P) as are the positions of a
non-specific complex (NS), the specific complex (SP) and the complex that is
super-shifted by addition of the Oct-1 antibody (SS).
Nucleic Acids Research, 2005, Vol. 33, No. 13 4363region (308 bp, from  751 to  443) removes the Oct-1 site
and eliminates induction of the SV40 promoter by BMP-4
(Figure 7B). We conclude that BMP induction requires both
the distal Oct-1 site (BRE1) and sequences within or ﬂanking
a 20 bp region of a proximal element (BRE2).
DISCUSSION
Gata2 is a transcription factor expressed in multiple tissues
including those of the hematopoietic (31,53–55) and nervous
systems (56–58). The gene is likely to be regulated by
distinct pathways in diverse tissues, but the early activation
in ventral and lateral embryonic mesoderm and ectoderm is
fully dependent on the BMP signaling pathway. The gata2
gene is therefore a component of the BMP syn-expression
network. Our results show that BMP signals activate the
gata2 promoter, dependent on the participation of R-Smad
proteins, and requiring a binding site for the POU
homeodomain transcription factor Oct-1, which functions in
conjunction with a more proximal regulatory region. It
is important to point out that the gata2 gene is expressed
broadly throughout the BMP syn-expression domain, at the
stages of development we are investigating. The Oct-1 binding
site is therefore presumably involved in mediating this
broad activation of the gata2 promoter, and our experiments
do not address whether it continues to be important for the
regulatory mechanisms that later restrict expression of the
gata2 gene to deﬁned cell lineages, e.g. in the hematopoietic
system.
Although originally considered a ubiquitous transcription
factor (50), Xenopus Oct-1 is expressed during embryogenesis
in a restricted pattern (59) in regions of both ectoderm and
mesoderm coincident with gata2 expression. Furthermore,
mis-expression of Oct-1 in developing Xenopus embryos
causes axis defects (59), suggesting that Oct-1 might be a
component of early dorsal–ventral patterning. Axis
defects are similarly caused by expression of a dominant-
negative Gata2 isoform (32). There is precedence for media-
tion of the BMP pathway by POU domain proteins, provided
ﬁrst by studies of the Dpp-regulated vestigial gene in
Drosophila (60). A sequence from the vestigial locus,
known as the vgQ enhancer, is directly regulated by Dpp
signaling through binding of Mad to this element (17).
However, over-expression of the POU domain protein Drifter
(DFR) expands the domain of LacZ expression in transgenic
ﬂies that carry a vgQ-LacZ reporter (60).Subsequent promoter
deletion analysis identiﬁed a DFR binding element in close
proximity to the already characterized Mad binding element,
consistent with the idea that full Dpp-mediated transcriptional
activity requires the cooperation of both DFR and Mad
proteins at the vestigial promoter (60). Ectopic expression
of Dpp or a constitutively activated form of the Dpp receptor
Thick Veins fails to activate DFR expression, implying
that DFR itself is not a direct target of the Dpp signaling
pathway (60).
Recently,Caoetal.(26) found using a one-hybrid assaythat
Oct-25 binds to and stimulates the activity of the Xvent-2B
promoter, and that Oct-25 can also bind to components of
the BMP signaling pathway, including Smad1, Smad4 and
Xvent-2. Interestingly, Oct-25 expression is not sufﬁcient
for activation of the Xvent-2B promoter, but requires the
cis-elements that interact with Smad1/4 and OAZ. This is
analogous to the situation we describe with the gata2 pro-
moter, in that Oct-1 binding is not sufﬁcient but requires in
addition the more proximal BRE2 sequences, which we pro-
pose are direct or indirect targets for Smads and/or other
activators. Our preliminary attempts at further deﬁning the
B
A
C
Figure 7. The BRE1 cooperates with a distinct BRE2 element located at
 100 bp proximal to the Oct-1 binding site. (A) The SV40 minimal promoter
was used to test if the BRE activity could be transferred to a heterologous
promoter.TheSV40promoteritselfisnotinducedbyBMP4.Shownbelowthis
construct are six additional reporters containing various regions of the gata2
upstream region as indicated on the map below, placed upstream of the SV40
promoter. Sequences from  819 to  685 containing just the BRE1 (construct
#1,134bp)doesnotfunctionasaBRE,whereastheentireregionfrom 819to
 443 (construct #2, 377 bp) is sufficient to mediate  3-fold activation of the
SV40 promoter by BMP-4.Subsequent constructs delineated a 20 bp sequence
(between  666 and  646) that is necessary for BRE activity (designated
BRE2). Dark grey boxes indicate gata2 genomic sequences, black boxes
indicate the SV40 promoter, and the light grey box represents the luciferase
reportergene.BlackboxesonthemapbelowrepresenttheBREsequences.(B)
BRE2 is not active in the absence of BRE1. This is shown by transferring
sequences from  751 to  443 upstream of the SV40 promoter, which fails
to support BMP-mediated induction. Therefore, neither BRE1 nor BRE2 has
activityonitsown,butthetworegionscooperatetomediatetheresponse.Boxes
represent sequences as in (A). (C) Sequences around the BRE2, defined so
far by the 20 bp region between  646 and  666. Potential Smad (AGAC) or
Vent-2 (ATTA) binding sites are indicated, although we have so far been
unable to confirm that they are functional, either for binding or activity (data
not shown).
4364 Nucleic Acids Research, 2005, Vol. 33, No. 13key sequences of BRE2 by site-directed mutagenesis have not
yielded consistent results, perhaps indicating the presence of
overlapping or redundant elements that will require alternative
approaches to unravel.
There are two adjacent octamer sequences present in the
Xvent-2 promoter, neither of which matches exactly the single
site of the gata2 promoter. POU transcription factors
bind DNA via their unique POU domain, consisting of two
sub-domains: a POU-type homeodomain (POUH) and a POU-
speciﬁc domain (POUS), tethered to each other by a linker of
variable length and sequence (61). In the case of Oct-1,
both these domains are indispensable for DNA binding to
the octamer consensus sequence 50-ATGCAAAT-30 (62).
The Oct-1 binding site in the gata2 BRE1, 50-ATGTAAAG,
retains the four (underlined) essential bases, and overall is
identical at six of the eight nucleotides. Furthermore, super-
shift experiments using an antibody speciﬁc to Oct-1 suggest
that Oct-1 is the protein in Xenopus nuclear extracts that binds
to the gata2 BRE1. Mutations that abolish this binding also
block BMP-4 mediated induction of the gata2 promoter. How-
ever, at this point it seems feasible that Oct-25 could also bind
to the gata2 BRE1 (and also that Oct-1 might be able to
interact at the Xvent-2 promoter). Until speciﬁcity is further
documented,it seems reasonable toconsider that POU-domain
octamer binding proteins represent functional components that
mediate BMP signaling.
Based on the studies of the vestigial and Xvent-2 promoters,
and our data showing that Smad1 can substitute for BMP4,
while Smad6 blocks the BRE response, it seems likely
that Oct-1 functions with Smad1/4 and perhaps Vent
homeodomain proteins for activation of the gata2 promoter.
Our attempts to demonstrate that Smad1/4 or Vent2 bind
directly to sequences in the proximal BRE2 element have
so far yielded negative results, but this may be due torelatively
low binding afﬁnities or the requirement of additional
co-factors. Although the cooperating elements in the vestigial
locus were located within 25 bp of each other (60), it is
conceivable that proteins bound to the gata2 elements could
interact over larger distances, presumably facilitated by
DNA bending, since the Oct-1 POU domain can bend DNA
in vitro (63).
The 20 bp region deﬁned as the BRE2 has sequences that
might be capable of binding Smad (50-AGAC) and/or Vent (50-
TAAT) proteins (Figure 7C). The core sequence 50-TAAT-30
has been previously shown to be absolutely required for bind-
ing and activity of Xvent-2 (64,65). Xvent-2 is an excellent
candidate as a co-modulator of the gata2 response to BMP
signaling. First, it is a direct target of BMP-4 (66). Second,
zebraﬁsh embryos in which the Vent-related homeobox genes
vox and vent are inactivated by mutation have reduced expres-
sion of gata2 at mid-gastrula stages (67). Third, Xvent-2 can
associate with Smad1 to regulate the transcription of down-
stream target genes (68). Fourth, Xvent-2 and gata2
co-regulate the expression of Xvent-1, placing both these
genes in the same ventralizing pathway (33). Collectively,
these data are consistent with the hypothesis that gata2 expres-
sion is induced by a combination of Smad1/4, Oct-1 and
Xvent-2 (and perhaps other co-factors), followed by coopera-
tion of these transcription factors to activate other proteins
important for ventral fate and the speciﬁcation of ventrally
derived tissues.
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